On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Physicians treating patients with fever, aching joints, and other viral symptoms might want to ask about patients' travel history. If these patients have been to the Caribbean or other places with hot climates they could be infected with Chikungunya virus, known also as CHIK-V. The disease has been reported in all but 3 US states.
Innovative App for Skin Cancer Diagnosis Launched on World Cancer Day 2015
A new, free mobile application that could potentially detect skin cancer, was made available on World Cancer Day, February 4, 2015, for physicians and dermatologists in the United States, United Kingdom, and Australia.
Unexpected Weight Gain Post Fecal Matter Transplant
A woman successfully treated with fecal microbiota transplantation (FMT) for recurrent Clostridium difficile(C. difficile) from an overweight donor's stool found herself quickly gaining weight afterward to the point of obesity, reported a case published in the journal Open Forum Infectious Diseases.
Five cases of measles in a suburban Illinois infant care center have added to concerns the preventable but highly contagious illness is spreading. The children, all under 12 months old, are too young to be vaccinated, but they appear to have contracted the illness from an unvaccinated adult. Meanwhile, bucking a trend, a New York legislator wants to make philosophical objections to mandatory vaccination legal in that state.
Stroke: Magnesium Sulfate Fails Prehospital Trial
Cross magnesium sulfate off the list of potential treatments to prevent post-stroke brain damage. Writing in the New England Journal of Medicine, Jeffrey Saver, MD and colleagues reported on FASTMAG, a test in which paramedic ambulance crews administered magnesium sulfate to apparent stroke patients at the site of the 911 call. The treatment was shown to be safe, with no difference in mortality between the treatment group and patients who got a placebo. But there was no significant shift in 90-day disability outcomes.
Smoking Linked to Higher Risk of Death among Colorectal Cancer Survivors
Colorectal cancer survivors who smoke cigarettes were found to face more than twice the risk of death than non-smoking survivors, corroborating existing evidence that cigarette smoking is associated with colorectal cancer-specific mortality.
Cities' Link to Asthma Disputed by Recent Study
February 3rd 2015Challenging previous research, John Hopkins University investigators claimed race, poverty, and ethnicity - not residing in urban areas - were greater forecasters of asthma. However, they cautioned their study did not determine whether location is linked to a worsening in symptoms.
Model Highlights New Parasitic Infection Risk Factor
February 3rd 2015Using an innovative predictive model, researchers at the University of Adelaide in Australia discovered that urban sprawl increased the transmission of parasitic worms found in rats and the parasites to humans and other forms of wildlife.
Clinicians Encouraged To Discuss Sexual Function with IBD Patients
While many women (and men) with inflammatory bowel disease (IBD) have experienced some level of sexual dysfunction, according to recent data, only less than one in 10 female patients revealed their physicians speak with them about this issue.
New Minimally Invasive Test IDs Patients for Barrett's Esophagus Screening
A new minimally invasive cell sampling device, Cytosponge-TFF3, coupled with assessment of trefoil factor 3 expressions, can successfully identify patients with reflux symptoms who warrant endoscopy to diagnose Barrett's esophagus.
AbbVie Wins European Approval for Hepatitis C Treatment
February 1st 2015Following similar approvals in the United States and Canada, AbbVie has been granted marketing authorization by the European Commission for an all-oral, interferon-free combination drug for the treatment of genotypes 1 and 4 chronic hepatitis C infection.